Remecial, Daniella .
HRN: 26-11-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/22/2024
11/01/2024
IV
100mg
Q6h
AGE With Moderate Dehydration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes